Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials

Besmir Nreu; Ilaria Dicembrini; Federico Tinti; Giorgio Sesti; Edoardo Mannucci; Matteo Monami

doi:10.1016/j.numecd.2020.03.013

Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2020.03.013 ◽

2020 ◽

Vol 30 (7) ◽

pp. 1106-1114 ◽

Cited By ~ 2

Author(s):

Besmir Nreu ◽

Ilaria Dicembrini ◽

Federico Tinti ◽

Giorgio Sesti ◽

Edoardo Mannucci ◽

...

Keyword(s):

Heart Failure ◽

Atrial Fibrillation ◽

Randomized Controlled Trials ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Major Cardiovascular Events ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Author response for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v3/response1 ◽

2019 ◽

Author(s):

Edoardo Mannucci ◽

Ilaria Dicembrini ◽

Besmir Nreu ◽

Matteo Monami

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Author Response ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review4 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review2 ◽

2019 ◽

Author(s):

Per Wändell

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review5 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review3 ◽

2019 ◽

Author(s):

Luis M. Ruilope

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2017.03.163 ◽

2017 ◽

Vol 240 ◽

pp. 414-421 ◽

Cited By ~ 24

Author(s):

Matteo Monami ◽

Stefania Zannoni ◽

Laura Pala ◽

Antonio Silverii ◽

Francesco Andreozzi ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Author response for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/response1 ◽

2019 ◽

Author(s):

Edoardo Mannucci ◽

Ilaria Dicembrini ◽

Besmir Nreu ◽

Matteo Monami

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Author Response ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/decision1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text